Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-23

Clinical Trial Update: Dose Finding Trial of R21/Matrix-M in School Children [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial of the R21/Matrix-M malaria vaccine in schoolchildren is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • R21/Matrix-M

Snippet

Sponsor: University of Oxford | Conditions: Malaria (Plasmodium Falciparum) | Phase 2 | Status: RECRUITING